scholarly article | Q13442814 |
P356 | DOI | 10.1089/NEU.2006.23.1111 |
P698 | PubMed publication ID | 16866624 |
P50 | author | Joong Woo Leem | Q62132564 |
P2093 | author name string | Claire E Hulsebosch | |
Young Seob Gwak | |||
Taick Sang Nam | |||
Kwang Se Paik | |||
Huai Yu Tan | |||
P433 | issue | 7 | |
P921 | main subject | chronic pain | Q1088113 |
neuropathic pain | Q2798704 | ||
chronic neuropathic pain | Q58490835 | ||
P304 | page(s) | 1111-1124 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | Journal of Neurotrauma | Q15716774 |
P1476 | title | Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury | |
P478 | volume | 23 |
Q39177497 | Analgesic Effect of Recombinant GABAergic Cells in a Model of Peripheral Neuropathic Pain. |
Q39309945 | Baclofen as an adjuvant analgesic for cancer pain |
Q43075742 | Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics. |
Q46351844 | Bilateral hyperexcitability of thalamic VPL neurons following unilateral spinal injury in rats. |
Q36635432 | Cell transplantation for spinal cord injury: a systematic review |
Q37115250 | Cingulate GABA levels inversely correlate with the intensity of ongoing chronic knee osteoarthritis pain |
Q42548830 | Combination Drug Therapy for Pain following Chronic Spinal Cord Injury |
Q37448404 | Conditional gene deletion reveals functional redundancy of GABAB receptors in peripheral nociceptors in vivo |
Q38727831 | Current and Future Issues in the Development of Spinal Agents for the Management of Pain |
Q42776669 | Effect of intrathecal glycine and related amino acids on the allodynia and hyperalgesic action of strychnine or bicuculline in mice |
Q46320408 | Effects of Etanercept and Minocycline in a rat model of spinal cord injury |
Q60053955 | Ethanol-induced enhancement of inhibitory synaptic transmission in the rat spinal substantia gelatinosa |
Q37826940 | GABA and central neuropathic pain following spinal cord injury |
Q38188497 | GABA pharmacology: the search for analgesics. |
Q48324396 | How is chronic pain related to sympathetic dysfunction and autonomic dysreflexia following spinal cord injury? |
Q53666755 | Inhibition of α5 subunit-containing GABAA receptors facilitated spinal nociceptive transmission and plasticity. |
Q35803351 | Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats: a pharmacologic and neurophysiological evaluation |
Q38832495 | Intrathecal Transplantation of Embryonic Stem Cell-Derived Spinal GABAergic Neural Precursor Cells Attenuates Neuropathic Pain in a Spinal Cord Injury Rat Model. |
Q37612317 | Intrathecal administration of GABA agonists in the vegetative state |
Q37851908 | Ion channel blockers and spinal cord injury |
Q37139432 | Locomotor dysfunction and pain: the scylla and charybdis of fiber sprouting after spinal cord injury |
Q34081579 | Loss of central inhibition: implications for behavioral hypersensitivity after contusive spinal cord injury in rats. |
Q36096233 | Modulation of Spinal GABAergic Inhibition and Mechanical Hypersensitivity following Chronic Compression of Dorsal Root Ganglion in the Rat. |
Q51167310 | Neonatal bladder inflammation induces long-term visceral pain and altered responses of spinal neurons in adult rats. |
Q39267599 | Neurobiological Effects of Morphine after Spinal Cord Injury |
Q37851055 | Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury |
Q41689858 | Neuronal-Glial Interactions Maintain Chronic Neuropathic Pain after Spinal Cord Injury. |
Q38247950 | Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms |
Q42080553 | Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury |
Q35948021 | Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines |
Q30357529 | Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases. |
Q43135694 | Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat. |
Q51712501 | Rapamycin suppresses microglial activation and reduces the development of neuropathic pain after spinal cord injury. |
Q37078246 | Recombinant neural progenitor transplants in the spinal dorsal horn alleviate chronic central neuropathic pain |
Q34421188 | Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat |
Q38318458 | Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches |
Q33897359 | Spinal cord transection-induced allodynia in rats--behavioral, physiopathological and pharmacological characterization |
Q47648437 | The H-Reflex as a Biomarker for Spinal Disinhibition in Painful Diabetic Neuropathy. |
Q35852049 | The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy |
Q37065365 | Validity of acute and chronic tactile sensory testing after spinal cord injury in rats |
Q89634678 | Viral Vector-Mediated Gene Transfer of Glutamic Acid Decarboxylase for Chronic Pain Treatment: A Literature Review |
Q48208357 | mir-500-Mediated GAD67 Downregulation Contributes to Neuropathic Pain. |
Search more.